COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,225 Articles (22,733 medRxiv, 8,492 bioRxiv)

Most recent first Previous |  Page 1122: Articles 11211-11220  | Next

Care Models for Long COVID: A Rapid Systematic Review
Decary, S., Dugas, M., Stefan, T., Langlois, L., Skidmore, B., Bhereur, A., LeBlanc, A.
10.1101/2021.11.17.21266404 — Posted: 2021-11-19
Effectiveness of digital contact tracing for COVID-19 in New South Wales, Australia
Vogt, F., Haire, B., Selvey, L., Kaldor, J.
10.1101/2021.11.18.21266558 — Posted: 2021-11-19
Transmission potential of vaccinated and unvaccinated persons infected with the SARS-CoV-2 Delta variant in a federal prison, July-August 2021
Salvatore, P. P., Lee, C. C., Sleweon, S., McCormick, D. W., Nicolae, L., Knipe, K., Dixon, T., Banta, R., Ogle, I., Young, C., Dusseau, C., Salmonson, S., Ogden, C., Godwin, E., Ballom, T., Ross, T., Wynn, N. T., David, E., Bessey, T. K., Kim, G., Suppiah, S., Tamin, A., Harcourt, J. L., Sheth, M., Lowe, L., Browne, H., Tate, J. E., Kirking, H. L., Hagan, L. M.
10.1101/2021.11.12.21265796 — Posted: 2021-11-19 Discussion: Onsite | Offsite
Reduced Incidence of Long-COVID Symptoms Related to Administration of COVID-19 Vaccines Both Before COVID-19 Diagnosis and Up to 12 Weeks After
Simon, M. A., Luginbuhl, R., Parker, R.
10.1101/2021.11.17.21263608 — Posted: 2021-11-18 Discussion: Offsite
Epithelial RIG-I inflammasome activation suppresses antiviral immunity and promotes inflammatory responses in virus-induced asthma exacerbations and COVID-19
Radzikowska, U., Eljaszewicz, A., Tan, G., Stocker, N., Heider, A., Westermann, P., Steiner, S., Dreher, A., Wawrzyniak, P., Ruckert, B., Rodriguez-Coira, J., Zhakparov, D., Huang, M., Jakiela, B., Sanak, M., Moniuszko, M., O`Mahony, L., Kebadze, T., Jackson, D. J., Edwards, M. R., Thiel, V., Johnston, S. L., Akdis, C., Sokolowska, M.
10.1101/2021.11.16.21266115 — Posted: 2021-11-17 Discussion: Onsite
SARS-CoV-2 RdRp is a versatile enzyme with proofreading activity and ability to incorporate NHC into RNA by using diphosphate form molnupiravir as a substrate
Wang, M., Wu, C., Liu, N., Zhang, F., Dong, H., Wang, S., Chen, M., Jiang, X., Gu, L.
10.1101/2021.11.15.468737 — Posted: 2021-11-17
IFITM dependency of SARS-CoV-2 variants of concern
Nchioua, R., Schundner, A., Kmiec, D., Prelli Bozzo, C., Zech, F., Koepke, L., Frick, M., Sparrer, K. M., Kirchhoff, F.
10.1101/2021.11.17.468942 — Posted: 2021-11-17
NUDT18 catalyzes hydrolysis of active metabolites of the antivirals Remdesivir and Ribavirin
Jemth, A.-S., Scaletti, E. R., Homan, E. J., Stenmark, P., Helleday, T., Michel, M.
10.1101/2021.11.16.468802 — Posted: 2021-11-17
Global Mutational Sweep of SARS-CoV-2: from Chaos to Order
Wang, X., Hu, M., Jin, Y., Wang, B., Zhao, Y., Liang, L., Yue, J., Ren, H.
10.1101/2021.11.16.468834 — Posted: 2021-11-17
The Delta variant of SARS-CoV-2 maintains high sensitivity to interferons in human lung cells
Nchioua, R., Schundner, A., Klute, S., Noettger, S., Zech, F., Koepke, L., Graf, A., Krebs, S., Blum, H., Kmiec, D., Frick, M., Kirchhoff, F., Sparrer, K.
10.1101/2021.11.16.468777 — Posted: 2021-11-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).